 |
 |
      |
|
| Arno Therapeutics is a biopharmaceutical company focused on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs |
 |
|
|  |
|
|
 |
|
|
|
|
 |
|
May 15, 2013 Arno Therapeutics to Present Positive, New Data Supporting the Potential of Onapristone in Endometrial and Breast Cancers at ASCO 2013 Annual Meeting more » May 10, 2013 Arno Therapeutics to Collaborate with Clarient for Development of Diagnostic Test more » April 8, 2013 Arno Therapeutics Reports Activated Progesterone Receptors Predictive of Response to Onapristone Data Presented Today at AACR Annual Meeting 2013 more » |
|
|
|
|
|
Arno Therapeutics, Inc. 200 Route 31 North Suite 104 Flemington, NJ 08822 (862) 703-7170 Main (908) 237-0071 Fax info@arnothera.com |
©2011 Arno Therapeutics, Inc. | Privacy Policy |